A kinetic analysis of the effects of β-phenylethylamine on the concentrations of dopamine and its metabolites in the rat striatum

Journal of Pharmaceutical Sciences

Volumn 86, Issue 4, 1997, Pages 487-496

  Sato, Shinji ^a   Tamura, Astushi ^a   Kitagawa, Shuji ^a   Koshiro, Akira ^a  

^a NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; DOPAMINE; DRUG METABOLITE; HOMOVANILLIC ACID; PHENETHYLAMINE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; CORPUS STRIATUM; DOPAMINE METABOLISM; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG ELIMINATION; GAS CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MASS SPECTROMETRY; NERVE ENDING; NONHUMAN; RAT;

EID: 0030911844     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js960192p     Document Type: Article

References (36)

1. Berry, M. D.; Scarr, E.; Zhu, M.-Y.; Paterson, I. A.; Juorio, A. V. Br. J. Pharmacol. 1994, 113, 1159-1166.
2. Oldendorf, W. H. Am. J. Physiol. 1971, 221, 1629-1639.
3. Juorio, A. V. Brain β-phenylethylamine: localization, pathways, and interrelation with catecholamines. In Progress in catecholamine research, part B: Central aspects. Neurology and Neurobiology, Vol. 42B, eds. Sandler, M., Dahlstrom, A., Belmaker, R. H., Eds.; Alan Liss: New York, 1988; pp 433-437.
4. Yu, P. H. Gen. Pharm. 1994, 25, 1527-1539.
5. Paterson I. A.; Juorio, A. V.; Boulton, A. A. J. Neurochem. 1990, 55, 1827-1837.
6. Durden, D. A.; Philips, S. R. J. Neurochem. 1980, 34, 1725-1732.
7. Dyck, L. E. Brain. Res. Bull. 1984, 12, 23-28.
8. Parker, E. M.; Cubeddu, L. X. J. Pharmacol. Exp. Ther. 1988, 245, 199-210.
9. Tang, H. Y. T.; Neff, N. H. J. Pharmacol. Exp. Ther. 1973, 187, 365-371.
10. Tyce, G. M.; Rorie, D. K. Life. Sci. 1985, 37, 2439-2448.
11. Hauger, R. L.; Skolnick, P.; Paul, S. M. Eur. J. Pharmacol. 1982, 83, 147-148.
12. Paetsch, P. R.; Greenshaw, A. J. Cell. Mol. Neurobiol. 1993, 13, 203-215.
13. Juorio, A. V.; Paterson, I. A.; Zhu, M.-Y. Eur. J. Pharmacol. 1994, 254, 213-220.
14. O'Reilly, R. L.; Davis, B. A. Prog. Neuro-Psychopharmacol. Biol. Psychiat. 1994, 18, 63-75.
15. Davis, B. A.; Boulton, A. A. Prog. Neuro-Psychopharmacol. Biol. Psychiat. 1994, 18, 17-45.
16. Sabelli, H. C.; Javaid, I. J. J. Neuropsychiatry. Clin. Neurosci. 1995, 7, 6-14.
17. Sato, S.; Koitabashi, T.; Koshiro, A. Biol. Pharm. Bull. 1994, 17, 1622-1629.
18. Sato, S.; Koitabashi, T.; Koshiro, A. Biol. Pharm. Bull. 1995, 18, 990-995.
19. Glowinski, J.; Iversen, L. L. J. Neurochem. 1966, 13, 655-669.
20. Kataoka, H.; Ohrui, S.; Miyamoto, Y.; Makita, M. J. Chromatogr. 1992, 578, 120-123.
21. Murai, S.; Saito, H.; Masuda, Y.; Itoh, T. J. Neurochem. 1988, 50, 473-479.
22. Pearce, L. B.; Roth, J. A. Arch. Biochem. Biophys. 1983, 224, 464-472.
23. Coyle, J. T.; Snyder, S. H. J. Pharmacol. Exp. Ther. 1969, 170, 221-231.
24. DeMet, E. M.; Vosmer, G.; Halaris, A. E. J. Neurochem. 1981, 36, 917-923.
25. Berman, M.; Shahn, E.; Weiss, M. F. Biophys. J. 1962, 2, 275-287.
26. Marquardt, D. W. J. Soc. Ind, Appl. Math. 1963, 11, 431-441.
27. Huebert, N. D.; Schwach, V.; Richter, G.; Zreika, M.; Hinze, C.; Haegele, K. D. Anal. Biochem. 1994, 227, 42-47.
28. Sato, S.; Koitabashi, T.; Koshiro, A. Biol. Pharm. Bull. 1994, 17, 1616-1621.
29. Sato, S.; Koshiro, A. Biol. Pharm. Bull. 1995, 18, 593-599.
30. Itoh, T.; Sawada, Y.; Lin, T.; Iga, T.; Hanano, M. J. Pharmacobio-Dyn. 1988, 11, 289-308.
31. Karoum, F.; Speciale, S. G. Jr.; Chuang, L.-W.; Wyatt, R. J. J. Pharmacol. Exp. Ther. 1982, 223, 432-439.
32. Horn, A. S. Br. J. Pharm. 1973, 47, 332-338.
33. Yamaoka, K.; Nakagawa, T.; Uno, T. J. Pharmacokinet. Biopharm. 1978, 6, 165-175.
34. Sheiner, L. B.; Stanski, D. R.; Vozeh, S.; Miller, R. D.; Ham, J. Clin. Pharmacol. Ther. 1979, 25, 358-371.
35. Westerink, B. H. C.; Korf, J. Eur. J. Pharmacol. 1976, 37, 249-255.
36. Weaterink, B. H. C.; Spaan, S. J. J. Neurochem. 1982, 38, 342-347.